Beijing Konruns Pharmaceutical Co Ltd (603590) — Financial Flexibility Index
Beijing Konruns Pharmaceutical Co Ltd (603590) has a Financial Flexibility Index of 0.20x as of September 2025. Free cash flow of CN¥113.71 Million (operating CF CN¥96.44 Million minus capex CN¥17.27 Million) represents 0% of total liabilities (CN¥563.43 Million). Check Beijing Konruns Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Konruns Pharmaceutical Co Ltd Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Beijing Konruns Pharmaceutical Co Ltd across 13 annual periods. See Beijing Konruns Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Beijing Konruns Pharmaceutical Co Ltd (2013–2025)
Year-by-year free cash flow to debt coverage for Beijing Konruns Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Beijing Konruns Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | CN¥169.13 Million | CN¥115.68 Million | CN¥598.51 Million | ▼ -49.5% |
| 2024 | 0.56x | CN¥276.27 Million | CN¥172.25 Million | CN¥493.52 Million | ▼ -22.0% |
| 2023 | 0.72x | CN¥300.27 Million | CN¥199.35 Million | CN¥418.44 Million | ▼ -22.0% |
| 2022 | 0.92x | CN¥216.00 Million | CN¥119.69 Million | CN¥234.68 Million | ▼ -5.9% |
| 2021 | 0.98x | CN¥235.56 Million | CN¥70.91 Million | CN¥240.74 Million | ▲ +531.2% |
| 2020 | 0.16x | CN¥108.78 Million | CN¥58.41 Million | CN¥701.72 Million | ▼ -75.4% |
| 2019 | 0.63x | CN¥280.89 Million | CN¥262.00 Million | CN¥445.84 Million | ▼ -1.1% |
| 2018 | 0.64x | CN¥279.95 Million | CN¥263.11 Million | CN¥439.48 Million | ▼ -33.2% |
| 2017 | 0.95x | CN¥304.22 Million | CN¥270.49 Million | CN¥318.93 Million | ▼ -57.0% |
| 2016 | 2.22x | CN¥326.93 Million | CN¥148.26 Million | CN¥147.37 Million | ▲ +52.2% |
| 2015 | 1.46x | CN¥236.89 Million | CN¥191.80 Million | CN¥162.53 Million | ▲ +56.2% |
| 2014 | 0.93x | CN¥165.18 Million | CN¥130.98 Million | CN¥177.02 Million | ▼ -15.2% |
| 2013 | 1.10x | CN¥221.89 Million | CN¥163.72 Million | CN¥201.68 Million | — |